Palantir a high-risk investment with ’a one-of-a-kind growth and margin model’
LONDON - Reckitt Benckiser (LON:RKT) Group PLC, a leading consumer health and hygiene company, announced the appointment of Patricia Verduin as a Non-Executive Director, effective June 9, 2025. Verduin, the former Chief Technology Officer at Colgate Palmolive, brings extensive research and development experience to the Reckitt board.
Patricia Verduin’s career at Colgate Palmolive spanned from 2007 to 2022, where she held various senior roles in R&D and technology. She has also been serving as a Non-Executive at several other companies, including Ingredion (NYSE:INGR), FMC (NYSE:FMC), and Avient, since 2019. Her tenure at Reckitt will include joining the Compliance Committee starting in July 2025.
Sir Jeremy Darroch, Chair of the Reckitt Board, expressed enthusiasm about Verduin’s addition to the team, citing her valuable expertise in consumer goods organizations and technology. He emphasized that her experience as an R&D leader will be a significant asset to the Board.
Reckitt, known for its commitment to creating a cleaner, healthier world, is the force behind a portfolio of well-known brands such as Dettol, Lysol, and Enfamil. The company operates globally with around 40,000 employees and emphasizes innovation, consumer focus, and sustainability in its operations.
The company has confirmed that there are no additional details requiring disclosure under the Financial Conduct Authority’s Listing Rule 9.6.13R concerning Verduin’s appointment.
This announcement is based on a press release statement provided by RNS, the news service of the London Stock Exchange (LON:LSEG).
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.